Ipamorelin is a selective growth hormone secretagogue and ghrelin-receptor agonist, structured as a pentapeptide. It's studied for its ability to stimulate GH release with a narrower off-target profile than earlier-generation secretagogues like GHRP-6 — in particular, minimal impact on cortisol and prolactin in preclinical models, which makes it a common choice for isolating GH-axis effects in research designs.
Its selectivity and relatively clean pharmacological profile have made it a frequent reference compound in comparative secretagogue research and in combination studies with GHRH analogs like CJC-1295.
This product is intended strictly for laboratory research use. It is not a drug, dietary supplement, or food product, and is not evaluated or approved by the FDA for any use in humans or animals. It is not for human consumption.
Every lot is tested by an independent, accredited lab before it's listed — purity, heavy metals, endotoxins, and quantity — with the full Certificate of Analysis published and traceable to that specific lot.
[Identity confirmed on certificate]